ASX:AVH AVITA Medical (AVH) Stock Price, News & Analysis → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free AVH Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume27.28 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield0.30%Price TargetN/A Stock AnalysisStock Analysis Get AVITA Medical alerts: Email Address Ad Insider FinancialThousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" About AVITA Medical Stock (ASX:AVH)AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Read More Ad Insider FinancialThousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" AVH Stock News HeadlinesApril 7, 2024 | finance.yahoo.comAVITA Medical (NASDAQ:RCEL) investors are sitting on a loss of 42% if they invested five years agoMarch 17, 2024 | finance.yahoo.comThis AVITA Medical Insider Increased Their Holding By 250% Last YearApril 25, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… March 16, 2024 | finance.yahoo.comRCEL Jul 2024 20.000 putMarch 16, 2024 | finance.yahoo.comRCEL Jul 2024 12.500 putFebruary 25, 2024 | finance.yahoo.comAVITA Medical, Inc. (NASDAQ:RCEL) Just Reported And Analysts Have Been Lifting Their Price TargetsFebruary 23, 2024 | msn.comASX Health Stocks: Rural vet stock Apiam jumps 17pc on huge first halfFebruary 22, 2024 | benzinga.comAVITA Medical: Q4 Earnings InsightsApril 25, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… February 22, 2024 | finance.yahoo.comAVITA Medical Inc (RCEL) Reports Robust Revenue Growth in Q4 and Full-Year 2023February 21, 2024 | benzinga.comEarnings Preview: AVITA MedicalJanuary 18, 2024 | finance.yahoo.comInstitutional investors own a significant stake of 48% in AVITA Medical, Inc. (NASDAQ:RCEL)January 10, 2024 | finance.yahoo.comAVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business UpdateJanuary 4, 2024 | finance.yahoo.comAVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 25, 2023 | benzinga.comAVITA Medical Stock (NASDAQ:RCEL) Dividends: History, Yield and DatesNovember 28, 2023 | nasdaq.comAvita Medical (ASX:AVH) Price Target Decreased by 12.67% to 7.59November 21, 2023 | finance.yahoo.comAVITA Medical to Present at the Piper Sandler 35th Annual Healthcare ConferenceNovember 21, 2023 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About AVITA MedicalNovember 21, 2023 | msn.comREPORT: ASX wound care is rapidly becoming an ‘exciting subsector’November 20, 2023 | fool.com.auWhy is the Avita Medical share price crashing 14% today?November 20, 2023 | finance.yahoo.comAVITA Medical Updates Full Year 2023 GuidanceNovember 13, 2023 | fool.com.auThe Avita Medical share price just leapt 17%! What's going on?November 10, 2023 | finance.yahoo.comAVITA Medical, Inc. (NASDAQ:RCEL) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | markets.businessinsider.comAVITA Medical Shares Up 13% As Revenue Surges In Q3November 10, 2023 | marketwatch.comAvita Medical Shares Rise After Strong 3QNovember 9, 2023 | fool.com.auWhy is the Avita Medical share price rocketing 24% today?November 9, 2023 | msn.comASX Health Stocks: AVITA flies as high as 24pc after providing a big, bullish guidanceSee More Headlines Receive AVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2019Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:AVH CUSIPN/A CIKN/A Webwww.avitamedical.com Phone661-367-9170FaxN/AEmployees207Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-35,380,000.00 Net Margins-70.56% Pretax MarginN/A Return on Equity-52.89% Return on Assets-25.35% Debt Debt-to-Equity Ratio86.45 Current Ratio7.88 Quick Ratio9.32 Sales & Book Value Annual Sales$50.14 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.47 Book ValueA$1.91 per share Price / BookN/AMiscellaneous Outstanding Shares128,530,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.29 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. James M. Corbett (Age 66)CEO, President & Executive Director Comp: $1.77MMr. David O'Toole (Age 65)Chief Financial Officer Comp: $878.88kMs. Donna Shiroma (Age 61)General Counsel, Chief Compliance Officer & Secretary Comp: $1.05MMr. David FencilSenior Vice President of Global OperationsDr. Katie Bush Ph.D.Senior Vice President of Scientific & Medical AffairsMs. Jessica EkebergInvestor Relations ExecutiveMs. Debbie GarnerSenior Vice President of Global Marketing & StrategyMr. Rob HallSenior Vice President of Human ResourcesMr. Terry BromleySenior Vice President of Global SalesDr. Niraj Doshi J.D.P.M.P., Ph.D., Senior Vice President of Product Development & Program ManagementMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersJames CorbettSold 1,445 sharesTotal: $6,025.65 ($4.17/share)Jeremy Curnock-CookSold 2,500 sharesTotal: $30,120.00 ($12.05/share)Cary VanceSold 7,092 sharesTotal: $30,424.68 ($4.29/share) AVH Stock Analysis - Frequently Asked Questions How were AVITA Medical's earnings last quarter? AVITA Medical, Inc. (ASX:AVH) announced its earnings results on Thursday, February, 28th. The company reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. AVITA Medical had a negative trailing twelve-month return on equity of 52.89% and a negative net margin of 70.56%. What other stocks do shareholders of AVITA Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other AVITA Medical investors own include AVITA MED LTD/S (AVMXY), Audentes Therapeutics (BOLD), Northern Dynasty Minerals (NAK), Orchid Island Capital (ORC), AVITA Medical (RCEL), Editas Medicine (EDIT), AMA Group (AMA), 88 Energy (88E), Fortune Minerals (FT) and Lynas Rare Earths (LYC). This page (ASX:AVH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
